Dr. Matthias Wiedenfels is a consultant in our corporate practice
Matthias is our industrial expert in our global healthcare practice and advises on takeover situations, M&A transactions and on all pharmaceutical and healthcare matters.
He is an expert in corporate governance, corporate strategy, compliance, corporate law and pharma law. As the former CEO of STADA Arzneimittel AG, he played a decisive role in the takeover of the company by Bain Capital and Cinven, and in many other major transactions.
As a co-author of the "Pharma und Life Science" handbook, Matthias is a recognised expert for pharma law and for compliance.
With his industrial expertise, his transactional experience and his management know-how, Matthias is strengthening our corporate and healthcare advisory practice for our clients.
Beside his consultancy role for Ashurst, Matthias is an investor and entrepreneur in the healthcare market.
Matthias studied law in Heidelberg, Montpellier and Freiburg. He was admitted to bar in 2001 and published a multitude of professional articles and handbooks. He speaks English and French and is an advisory board member on various national and international companies.
Legal Updates
-
Legal Update
05 Apr 2023 Update on the legislative initiative against supply shortages in drug procurement
-
Legal update
21 Mar 2023 Innovation in biotechnology is driven by automatization and AI
-
corporate update
27 Jan 2021 Update on regulatory restrictions for financial investors in the German healthcare sector
